{"id":"https://openalex.org/W4411288198","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p5-02-16","title":"Abstract P5-02-16: Thymidine kinase activity as a prognostic biomarker for first line CDK4/6 inhibitor efficacy in the Personalised Disease Monitoring in Metastatic Breast Cancer study","display_name":"Abstract P5-02-16: Thymidine kinase activity as a prognostic biomarker for first line CDK4/6 inhibitor efficacy in the Personalised Disease Monitoring in Metastatic Breast Cancer study","publication_year":2025,"publication_date":"2025-06-13","ids":{"openalex":"https://openalex.org/W4411288198","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p5-02-16"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3265.sabcs24-p5-02-16","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p5-02-16","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.sabcs24-p5-02-16","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026261167","display_name":"Sacha Jon Howell","orcid":"https://orcid.org/0000-0001-8141-6515","observed_orcids":["https://orcid.org/0000-0001-8141-6515"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sacha Howell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5118143732","display_name":"Bergqvist Mattias","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bergqvist Mattias","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043433198","display_name":"Williams Amy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Williams Amy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Mouhanna Pia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mouhanna Pia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Albu-Kareem Ahmed","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Albu-Kareem Ahmed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021395985","display_name":"Ellinor Elinder","orcid":"https://orcid.org/0000-0001-8596-5327","observed_orcids":["https://orcid.org/0000-0001-8596-5327"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elinder Ellinor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051271379","display_name":"Eriksson Olle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eriksson Olle","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061392536","display_name":"Kavanagh Amy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kavanagh Amy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122649825","display_name":"Karolina Larsson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Larsson Karolina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049566511","display_name":"Monika Umi\u0144ska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Uminska Monika","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5112303170","display_name":"E Pasqualini Maria","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ekholm Maria","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"12_Supplement","first_page":"P5","last_page":"02"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thymidine-kinase-activity","display_name":"thymidine kinase activity","score":0.9440000057220459},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.8799999952316284},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9319999814033508},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9399999976158142},{"id":"https://openalex.org/keywords/first-line-endocrine-therapy","display_name":"first-line endocrine therapy","score":0.7940000295639038},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-her2-negative-breast-cancer","display_name":"estrogen receptor-positive HER2-negative breast cancer","score":0.8629999756813049},{"id":"https://openalex.org/keywords/aromatase-inhibitors","display_name":"aromatase inhibitors","score":0.8149999976158142},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.902999997138977},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9589999914169312},{"id":"https://openalex.org/keywords/serum-biomarkers","display_name":"serum biomarkers","score":0.6430000066757202},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.6330000162124634},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.33399999141693115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7383497357368469},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.7232033610343933},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.634553074836731},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5169134140014648},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49652916193008423},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4840030372142792},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4565633237361908},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4414484202861786},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4012409448623657},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12379652261734009},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3265.sabcs24-p5-02-16","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p5-02-16","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.sabcs24-p5-02-16","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7128486816","https://openalex.org/W4411291312","https://openalex.org/W4396588018","https://openalex.org/W4322770345","https://openalex.org/W3011979269","https://openalex.org/W4220722694","https://openalex.org/W2789284916","https://openalex.org/W7125587867","https://openalex.org/W4411288700","https://openalex.org/W7130706928"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"There":[2],"is":[3,23,64,94,437,480,483],"an":[4,24,80,484],"unmet":[5],"need":[6],"for":[7,221,453,487,524],"biomarkers":[8],"that":[9,69,435],"improve":[10],"prediction":[11],"of":[12,34,113,142,148,270,287,306,328,465,543],"treatment":[13,315],"efficacy":[14,529],"in":[15,30,48,53,111,442,491,530,535],"metastatic":[16],"breast":[17],"cancer":[18],"(MBC).":[19],"Thymidine":[20,517],"kinase":[21,518],"(TK)":[22],"enzyme":[25],"with":[26,73,79,167,249,419,445,470],"a":[27,45,65,85,438,521],"critical":[28],"role":[29],"DNA":[31],"synthesis":[32],"downstream":[33],"the":[35,49,168,196,239,313,326,342,430,458,531,544],"CDK4/6":[36,86,448,527],"pathway.":[37],"We":[38],"assessed":[39,102],"serum":[40],"TK":[41],"activity":[42,519],"(TKa)":[43],"as":[44,88,450,520],"prognostic":[46,440,522],"biomarker":[47,66,441,486,523],"Personalised":[50,532],"Disease":[51,533],"Monitoring":[52,534],"Metastatic":[54,536],"Breast":[55,537,547],"Cancer":[56,538,548,561],"(PDM-MBC)":[57],"study.":[58],"Method:":[59],"The":[60,175,225],"PDM-MBC":[61,431],"study":[62,68,539],"(NCT04597580)":[63],"development":[67],"enrolled":[70],"97":[71],"patients":[72,210,417,443,462],"estrogen":[74],"receptor-positive,":[75],"HER2-negative":[76],"MBC":[77],"treated":[78,418,444],"aromatase":[81],"inhibitor":[82,87,449,528],"(AI)":[83],"plus":[84],"1st":[89],"line":[90,526],"endocrine":[91],"therapy.":[92],"Follow-up":[93],"ongoing":[95],"until":[96,161],"May":[97],"2026.":[98],"Computed":[99],"tomography":[100],"(CT)":[101],"by":[103,338],"RECIST":[104],"1.1":[105],"(and":[106],"magnetic":[107],"resonance":[108],"imaging":[109,155],"(MRI)":[110],"case":[112],"bone-predominant":[114],"disease)":[115],"was":[116,165,193,247],"performed":[117],"every":[118,124],"3":[119],"months":[120,126,254,264],"year":[121],"1":[122,144,147],"and":[123,157,180,185,189,201,217,228,232,284,319,325,333,349,361,376,389,447,468],"3-4":[125],"thereafter":[127,152],"or":[128,407,409],"earlier":[129],"if":[130],"clinically":[131],"indicated.":[132],"Serum":[133],"samples":[134],"were":[135,230,310,414],"collected":[136],"at":[137,153,215,245,405,463,476],"baseline":[138],"(BL),":[139],"day":[140,146],"15":[141],"cycle":[143,149,316,460],"(C1D15),":[145],"2":[150],"(C2D1),":[151],"each":[154],"timepoint":[156],"subsequent":[158,329],"doctor\u2019s":[159],"visit":[160],"disease":[162,489],"progression.":[163],"TKa":[164,172,178,182,212,237,308,324,404,411,436,455,474,482],"analyzed":[166],"FDA":[169,240],"cleared":[170],"DiviTum\u00d2":[171],"assay":[173],"(Biovica).":[174],"association":[176],"between":[177,341,402,416],"levels":[179],"early":[181,307,410,466],"dynamic":[183,412],"patterns":[184,305,413],"progression-free":[186],"survival":[187,191],"(PFS)":[188],"overall":[190],"(OS)":[192],"evaluated":[194],"using":[195],"Kaplan\u2013Meier":[197],"method,":[198],"logrank":[199,339],"test":[200,340],"univariable":[202],"Cox":[203],"regression":[204],"analysis.":[205],"Results:":[206],"In":[207,396,429],"total,":[208],"86":[209],"had":[211,219],"results":[213,220],"available":[214],"BL":[216,246,323],"77":[218],"all":[222],"three":[223],"timepoints.":[224],"median":[226,347,403],"PFS":[227,251,331,348,355,370,383],"OS":[229,261,334,350,362,377,390],"20.8":[231],"51.8":[233],"months,":[234],"respectively.":[235],"High":[236],"(above":[238],"stipulated":[241],"cut-off":[242],"250":[243],"DuA)":[244],"associated":[248],"shorter":[250,260],"(median":[252,262],"13.5":[253],"vs":[255,265,422],"not":[256,351],"reached":[257],"[NR],":[258],"p=0.002),":[259],"30.3":[263],"51.8,":[266],"p=0.017),":[267],"higher":[268,285],"risk":[269,286,464],"progression":[271,467],"(hazard":[272],"ratio":[273],"[HR]":[274],"2.46,":[275],"95%":[276,291],"confidence":[277],"interval":[278],"[CI]":[279],"1.37":[280],"to":[281,294,300,366,374,380,387,394,426],"4.44,":[282],"p=0.003)":[283],"death":[288],"(HR":[289],"2.53,":[290],"CI":[292],"1.15":[293],"5.58,":[295],"p=0.022).":[296],"Using":[297],"\u2265100":[298],"DuA":[299],"define":[301],"high":[302],"TKa,":[303],"four":[304,343],"dynamics":[309,456],"observed":[311,415],"during":[312,457],"first":[314,459,525],"(BL,":[317],"C1D15":[318,406],"C2D1)":[320],"based":[321],"on":[322],"level":[327],"suppression.":[330],"(p=0.003)":[332],"(p=0.03)":[335],"differed":[336],"significantly":[337],"groups:":[344],"Low-Low-Low":[345],"(n=14)":[346],"reached;":[352],"High-Low-Low":[353],"(n=26)":[354],"23.8m":[356],"(95%CI":[357,364,372,385,392],"can\u2019t":[358],"be":[359],"calculated)":[360],"51.8m":[363],"15.4":[365],"88.1);":[367],"High-Low-High":[368],"(n=24)":[369],"17.5m":[371],"10.2":[373],"24.8)":[375],"34.3m":[378],"(95%CI15.1":[379],"53,7)":[381],"High-High-High":[382],"10.3m":[384],"1.73":[386],"18.9)":[388],"30.3m":[391],"15.1":[393],"45.6)":[395],"exploratory":[397],"analyses":[398],"no":[399],"significant":[400],"differences":[401],"C2D1,":[408],"palbociclib":[420],"(n=48)":[421],"ribociclib":[423],"(n=29),":[424],"p=0.33":[425],"1.0.":[427],"Conclusions:":[428],"study,":[432],"we":[433],"confirm":[434],"valuable":[439],"AI":[446],"first-line":[451],"therapy":[452],"MBC.":[454,492],"identifies":[461],"those":[469],"more":[471],"prolonged":[472],"response.":[473],"analysis":[475],"later":[477],"time":[478],"points":[479],"ongoing.":[481],"encouraging":[485],"personalized":[488],"monitoring":[490],"Citation":[493],"Format:":[494],"Sacha":[495],"Howell,":[496],"Bergqvist":[497],"Mattias,":[498],"Williams":[499],"Amy,":[500,510],"Mouhanna":[501],"Pia,":[502],"Albu-Kareem":[503],"Ahmed,":[504],"Elinder":[505],"Ellinor,":[506],"Eriksson":[507],"Olle,":[508],"Kavanagh":[509],"Larsson":[511],"Karolina,":[512],"Uminska":[513],"Monika,":[514],"Ekholm":[515],"Maria.":[516],"[abstract].":[540],"In:":[541],"Proceedings":[542],"San":[545,554],"Antonio":[546],"Symposium":[549],"2024;":[550],"2024":[551],"Dec":[552],"10-13;":[553],"Antonio,":[555],"TX.":[556],"Philadelphia":[557],"(PA):":[558],"AACR;":[559],"Clin":[560],"Res":[562],"2025;31(12":[563],"Suppl):Abstract":[564],"nr":[565],"P5-02-16.":[566]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2025-10-10T00:00:00"}